# Nippon Protein Co., Ltd. Ashikaga Plant – FDA Inspection, Jun 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/5738b078-e9a6-4856-9102-053abac634de
Source feed: FDA_Inspections

> FDA inspection 1061073 of Nippon Protein Co., Ltd. Ashikaga Plant, June 22, 2018. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061073
- Company Name: Nippon Protein Co., Ltd. Ashikaga Plant
- Inspection Date: 2018-06-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1274601 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/34dcc5b9-ab4b-4337-b9a1-58f7756b37a4)
- FDA Inspection 951453 - 2015-11-20
- FDA Inspection 702060 - 2010-11-17

## Related Officers

- [Satheesh Thomas](https://www.keypedia.com/people/satheesh-thomas/8009b8a5-40f5-4791-b0e9-a7c855e3afd4)

Company: https://www.keypedia.com/companies/nippon-protein-co-ltd-ashikaga-plant/ccd4e515-8d9e-4f63-9a5d-b117cf2659d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
